 "Rallis India dips 6% on disappointing Q3 results as PAT falls 13% YoY")
Shares of Rallis India dipped 6 per cent to Rs 275.55 on the BSE in Thursday’s intra-day trade after the company reported a 13.3 per cent year-on-year (YoY) fall in its profit after tax (after exceptional items) at Rs 40 crore in December quarter (Q3FY22). The Tata Group company had posted a net profit of Rs 46 crore in Q3FY21.
The drag in the bottomline performance was largely on account of higher depreciation owing to recently commissioned capacity along with lower other income (down 28 per cent YoY). The agrochemicals company reported revenue growth of 10.1 per cent YoY to Rs 628.1 crore, led by international business growth of 19 per cent YoY. Operating profit margin (OPM) improved 20 bps YoY to 10.7 per cent.
The management said the erratic monsoon season this year has not favoured agri input companies as excessive rainfall continued into Q3 in the southern states. Despite these challenges, domestic crop care business grew at 9.4 per cent and exports by 19 per cent during the quarter.
The seeds industry continued to face headwinds due to restrictions for sale of paddy and maize hybrids in some states. The supply chain challenges continued into Q3 with availability being a challenge for certain intermediates as well as steep inflation in prices, the management said.
In spite of multiple disruptions and challenges, the company has faced during the quarter, long term strategy remains on track. The raw material availability and costs continue to be challenging. The elect commodity prices are good and export demand for crop protection is also favourable. Overall Rabi sown area in India remains stable, the company said in a press release.
“The company has been working on backward integration of few molecules along with increasing capacity for few active ingredients to cater to international market. This would eventually translate into better financial performance ahead. Apart from this, diversifying into Rabi focused portfolio over the time could improve growth outlook in long run,” said brokerage ICICI Securities in a note.
The drag in the bottomline performance was largely on account of higher depreciation owing to recently commissioned capacity along with lower other income (down 28 per cent YoY). The agrochemicals company reported revenue growth of 10.1 per cent YoY to Rs 628.1 crore, led by international business growth of 19 per cent YoY. Operating profit margin (OPM) improved 20 bps YoY to 10.7 per cent.
The management said the erratic monsoon season this year has not favoured agri input companies as excessive rainfall continued into Q3 in the southern states. Despite these challenges, domestic crop care business grew at 9.4 per cent and exports by 19 per cent during the quarter.
The seeds industry continued to face headwinds due to restrictions for sale of paddy and maize hybrids in some states. The supply chain challenges continued into Q3 with availability being a challenge for certain intermediates as well as steep inflation in prices, the management said.
In spite of multiple disruptions and challenges, the company has faced during the quarter, long term strategy remains on track. The raw material availability and costs continue to be challenging. The elect commodity prices are good and export demand for crop protection is also favourable. Overall Rabi sown area in India remains stable, the company said in a press release.
“The company has been working on backward integration of few molecules along with increasing capacity for few active ingredients to cater to international market. This would eventually translate into better financial performance ahead. Apart from this, diversifying into Rabi focused portfolio over the time could improve growth outlook in long run,” said brokerage ICICI Securities in a note.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%